LAVAL, Quebec, April 29, 2020 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the U.S. Food and Drug…Original Article
FDA Approves Ortho Dermatologics’ Labeling for Jublia (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old
